"Today, what we output is almost entirely for the domestic market," said Dr. Arnaud Bourgeois, vice president and global director of biology at Ceva. "The new facility will double our domestic output while also allowing for expansion globally." The 55,000-square-foot facility will have state-of-the-art operations and the capability to produce both standard and vector vaccines. It is expected to employ 80 production, research and development staff by 2015.
The facility's grand opening, which drew over 350 people, including customers, employees and other key officials, was held on May 3. The event featured opening remarks from Lenexa Mayor Michael Boehm and Kansas Secretary of Agriculture Dale Rodman, a tour of the new building and a mini scientific symposium for customers.
No comments:
Post a Comment